The prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis

ConclusionsThese results suggest that tumours that overexpress NRF2 have a worse clinical outcome. Thus, NRF2 expression could be a marker for the prognostic of breast cancer patients and, in the future, it would be pertinent to focus on improving treatment efficacy for patients with NRF2 overexpression.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research